BCC's goal in conducting this study was to provide a comprehensive overview of the imaging reagent market and its future direction, with emphasis on the use of reagents used in imaging technology. The study was also conducted to describe the types, market size and market leaders of imaging reagents. The report deals with the questions like: What is imaging? What are the current and potential applications of imaging reagents? What is the U.S./worldwide market value of imaging reagents? And finally, What is the market value of emerging imaging reagents?

The basic principles behind all types of imaging-x-rays, ultrasound, magnetic resonance, radiopharmaceuticals, and ionic and non-ionic-are also discussed with their usage over a five-year period from 2003 to 2008. The companies selling these products were brought to the forefront and also the factors affecting markets for these products, and how those markets are likely to change.

REASONS FOR DOING THE STUDY

The imaging market is changing due to the demand for safe and less costly reagents. The key, current objective focuses on the use of non-ionic reagents. The available alternatives and preferences in using various reagents for imaging have made the industry acutely aware of the issues covered in the report and the economic characteristics. This study looks at almost all the types of imaging markets affected by these factors. The rapid development of the technologies, major changes in market behavior, and the high impact that imaging technology has upon healthcare expenses all justify focusing on this segment.

Cardiovascular reagents have a large share of the imaging reagent market. More reagents are being discovered for the use in imaging technology with an emphasis on enhancers, which give more precise images. A bright future is foreseen for central nervous system and gastrointestinal imaging reagents over next few years.

The growth of acquisition strategies and collaborations by companies to gain better market share is also covered in this report. This study discusses the strengths and weaknesses of reagents in the market in light of new technologies, growing competition, and changing customer needs.

CONTRIBUTIONS OF THE STUDY AND FOR WHOM

This study contributes by bringing together in one place much of the information on new products and new technologies in imaging reagents as well as estimates of how the market will perform over the next five years.

Various types of imaging techniques including x-rays, ultrasound, magnetic resonance, and radiopharmaceuticals are presented. The regulations governing their use, technological descriptions and issues, applications, market factors and potential, and the projected market for 2003 and 2008 are also discussed.

This study will be of interest to the pharmaceutical industry, biochemical companies, physicians, and the research companies developing new imaging reagents.

SCOPE AND FORMAT

The scope of this study encompasses the different types of imaging technologies and the types of reagents used in those particular technologies. BCC analyzes each technique and concentrates on the manufacturers, new products, sales estimates, and market projections and market share information. Technological issues including the latest trends and developments are also discussed. Government regulations are examined, including those of the FDA, which approves the use of these reagents . Significant imaging reagent related patents are also listed.

METHODOLOGY

A comprehensive literature and patent search was conducted. The literature included technical newsletters and journals, as well as many other sources. The data was collected through interviews/mails of various analytical/chemical and pharmaceutical companies. This data was complied and the projections were based on such estimates such as the current number of end users, potential end users, likely unit prices, rates of consumption and the market trends.

INFORMATION SOURCES

BCC surveyed many companies to obtain data for this study. Included were manufacturers and the end users of the imaging reagents. We gathered the data from these industries, also spoke with officials of these industries, consulted newsletters, company literature, product literature, a host of technical articles, journals, indexes, and abstracts. Exhaustive investigations of databases by key terminology were performed. In addition, data was compiled from current financial and trade information and government sources.

INTRODUCTION

STUDY GOAL AND OBJECTIVES
REASONS FOR DOING THE STUDY
CONTRIBUTIONS OF THE STUDY AND FOR WHOM
SCOPE AND FORMAT
METHODOLOGY
INFORMATION SOURCES
RELATED PUBLICATIONS
AUTHOR'S CREDENTIALS
BCC ON-LINE SERVICES
- INTERNET

SUMMARY

MEDICAL DIAGNOSTICS
- MEDICAL REAGANTS

Summary Table:
U.S. SALES OF MEDICAL IMAGING REAGENTS BY TYPE, THROUGH 2008 ($ MILLIONS)
Summary Figure:
U.S. SALES OF MEDICAL IMAGING REAGENTS BY TYPE, 2001-2008 ($ MILLIONS)

OVERVIEW

WHAT IS MEDICAL IMAGING?
HISTORY OF IMAGING

Table 1 HISTORY OF IMAGING
Table 1 (CONTINUED)
- TYPES OF IMAGING TECHNIQUES
  - X-RAYS AND COMPUTED TOMOGRAPHY (CT)
  - ULTRASOUND
  - MAGNETIC RESONANCE IMAGING (MRI)
  - RADIOPHARMACEUTICAL IMAGING OR NUCLEAR MEDICINE
Table 2 USE OF CT/X-RAY, ULTRASOUND AND MRI
- THE IMAGING REAGENTS
Table 3 CHARACTERISTICS OF IMAGING TECHNIQUES
Table 4 ADVANTAGES OF NON-IONIC VS. IONIC CONTRAST AGENTS
Table 5 TYPES OF IODINE CONTAINING IMAGING REAGENTS FOR X-RAY/CT
Table 5 (CONTINUED)
Table 6 TYPES OF IONIC AND NON-IONIC IODINE CONTAINING IMAGING REAGENTS FOR X-RAY/CT
Table 7 USEFUL CLASSICAL RADIOPHARMACEUTICALS BY APPLICATION
Table 7 (CONTINUED)

REGULATORY ASPECTS

REGULATORY ASPECTS
- REGULATORY ASPECTS (CONTINUED)

Table 8 NEW AND GENERIC DRUG APPROVALS OF THE IMAGING REAGENTS, 2000-2003

INDUSTRY STRUCTURE

MARKET SHARE OF IMAGING REAGENTS

Table 9 MARKET SHARE OF COMPANIES IN MEDICAL IMAGING REAGENTS, 2002 (%)
Figure 1 MARKET SHARE OF COMPANIES IN MEDICAL IMAGING REAGENTS, 2002 (%)
- MARKET SHARE OF X-RAY AND CT IMAGING REAGENTS
Table 10 MARKET SHARE OF COMPANIES IN X-RAYS AND CT IMAGING REAGENTS, 2002 (%)
Figure 2 MARKET SHARE OF COMPANIES IN X-RAYS AND CT IMAGING REAGENTS, 2002 (%)
- MARKET SHARE OF ULTRASOUND IMAGING REAGENTS
Table 11 MARKET SHARE OF COMPANIES IN ULTRASOUND IMAGING REAGENTS, 2002 (%)
Figure 3 MARKET SHARE OF COMPANIES IN ULTRASOUND IMAGING REAGENTS, 2002 (%)
- MARKET SHARE OF MRI IMAGING REAGENTS
Table 12 MARKET SHARE OF COMPANIES IN MRI REAGENTS, 2002 (%)
Figure 4 MARKET SHARE OF COMPANIES IN MRI REAGENTS, 2002 (%)
- MARKET SHARE OF RADIOPHARMACEUTICAL IMAGING REAGENTS
Table 13 MARKET SHARE OF COMPANIES IN RADIOPHARMACEUTICAL IMAGING REAGENTS, 2002 (%)
Figure 5 MARKET SHARE OF COMPANIES IN RADIOPHARMACEUTICAL REAGENTS, 2002 (%)
- DEMAND AND USE
  - DEMAND AND USE (CONTINUED)

MARKET BY TECHNOLOGY

MARKET PICTURE OF IONIC AND NON-IONIC REAGENTS IN IMAGING

Table 14 U.S. SALES OF IONIC AND NON-IONIC AGENTS, THROUGH 2008 ($ MILLIONS)
Figure 6 U.S. SALES OF IONIC AND NON-IONIC AGENTS, 2001-2008 ($ MILLIONS)
- X-RAY AND COMPUTED TOMOGRAPHY (CT) REAGENTS
Table 15 REAGENTS USED IN X-RAY/CT
Table 15 (CONTINUED)
Table 16 U.S. SALES OF X-RAY/CT AGENTS, THROUGH 2008 ($ MILLIONS)
Figure 7 U.S. SALES OF X-RAY/CT AGENTS, 2001-2008 ($ MILLIONS)
Table 17 U.S. SALES OF IONIC AND NON-IONIC REAGENTS IN X-RAY/CT IMAGING, THROUGH 2008 ($ MILLIONS)
Figure 8 U.S. SALES OF IONIC AND NON-IONIC REAGENTS IN X-RAY/CT IMAGING, 2001-2008 ($ MILLIONS)
- ULTRASOUND REAGENTS
Table 18 REAGENTS USED IN ULTRASOUND
Table 18 (CONTINUED)
Table 19 U.S. SALES OF ULTRASOUND REAGENTS, THROUGH 2008 ($ MILLIONS)
Figure 9 U.S. SALES OF ULTRASOUND REAGENTS, 2001-2008 ($ MILLIONS)
- MRI CONTRAST AGENTS
Table 20 CONTRAST AGENTS USED IN MRI
Table 21 U.S. SALES OF MRI AGENTS, THROUGH 2008 ($ MILLIONS)
Figure 10 U.S. SALES OF MRI AGENTS, 2001-2008 ($ MILLIONS)
- NUCLEAR IMAGING REAGENTS/RADIOPHARMACEUTICAL IMAGING AGENTS
  - NUCLEAR IMAGING REAGENTS .. (CONTINUED)
Table 22 CONTRAST AGENTS USED IN RADIOPHARMACEUTICALS
Table 22 (CONTINUED)
Table 22 (CONTINUED)
Table 22 (CONTINUED)
Table 23 U.S. SALES OF RADIOPHARMACEUTICAL IMAGING REAGENTS, THROUGH 1008 ($ MILLIONS)
Figure 11 U.S. SALES OF RADIOPHARMACEUTICAL IMAGING REAGENTS, 2001-2008 ($ MILLIONS)

NEW DEVELOPMENTS

Table 24 X-RAY CONTRAST AGENTS UNDER DEVELOPMENT
Table 25 ULTRASOUND CONTRAST AGENTS UNDER DEVELOPMENT
Table 26 MRI CONTRAST AGENTS UNDER DEVELOPMENT
Table 27 RADIOPARMACEUTICAL CONTRAST AGENTS UNDER DEVELOPMENT

SIGNIFICANCE OF PATENTS

PATENTS BY TECHNOLOGY

Table 28 NUMBER OF PATENTS BY TECHNOLOGY, 1998-2003
Table 28 (CONTINUED)
Figure 12 NUMBER OF PATENTS, 1998-2003
Figure 13 NUMBER OF PATENTS BY YEAR, 1998-2003 (% OF TOTAL)
Figure 13 (CONTINUED)
Table 29 SIGNIFICANT PATENTS OF X-RAY /CT REAGENTS, 1998-2003
Table 29 (CONTINUED)
Table 29 (CONTINUED)
Table 29 (CONTINUED)
Table 29 (CONTINUED)
Table 29 (CONTINUED)
Table 29 (CONTINUED)
Table 30 SIGNIFICANT PATENTS OF ULTRASOUND REAGENTS, 1998-2003
Table 30 (CONTINUED)
Table 30 (CONTINUED)
Table 30 (CONTINUED)
Table 30 (CONTINUED)
Table 30 (CONTINUED)
Table 31 SIGNIFICANT PATENTS OF MAGNETIC RESONANCE IMAGING REAGENTS, 1998-2003
Table 31 (CONTINUED)
Table 31 (CONTINUED)
Table 31 (CONTINUED)
Table 31 (CONTINUED)
Table 31 (CONTINUED)
Table 32 SIGNIFICANT PATENTS OF RADIOPHARMACEUTICAL REAGENTS, 1998-2003
Table 32 (CONTINUED)
Table 32 (CONTINUED)
Table 32 (CONTINUED)
Table 33 SIGNIFICANT PATENTS OF OTHER IMAGING REAGENTS1, 1998-2003
Table 33 (CONTINUED)
Table 33 (CONTINUED)
- PATENTS BY COMPANY
Table 34 PATENTS BY ACUSPHERE INC. FOR REAGENTS USED IN IMAGING TECHNOLOGY, 1998-2003
Table 35 PATENTS BY AMERSHAM HEALTH/ NYCOMED FOR REAGENTS USED IN IMAGING TECHNOLOGY, 1998-2003
Table 35 (CONTINUED)
Table 36 PATENTS BY ALLIANCE PHARMACEUTICALS CORP. FOR REAGENTS USED IN IMAGING TECHNOLOGY, 1998-2003
Table 37 PATENTS BY BRACCO FOR REAGENTS USED IN IMAGING TECHNOLOGY, 1998-2003
Table 38 PATENTS BY EPIX MEDICAL INC. FOR REAGENTS USED IN IMAGING TECHNOLOGY, 1998-2003
Table 39 PATENTS BY EZ-EM INC. FOR REAGENTS USED IN IMAGING TECHNOLOGY, 1998-2003
Table 40 PATENTS BY IMARX THERAPEUTICS FOR REAGENTS USED IN IMAGING TECHNOLOGY, 1998-2003
Table 41 PATENTS BY IMMUNOMEDICS FOR REAGENTS USED IN IMAGING TECHNOLOGY, 1998-2003
Table 42 PATENTS BY MALLINCKRODT MEDICAL FOR REAGENTS USED IN IMAGING TECHNOLOGY, 1998-2003
Table 43 PATENTS BY MOLECULAR BIOSYSTEMS FOR REAGENTS USED IN IMAGING TECHNOLOGY, 1998-2003
Table 44 PATENTS BY NEORX FOR REAGENTS USED IN IMAGING TECHNOLOGY, 1998-2003
Table 45 PATENTS BY PHARMACYCLICS FOR REAGENTS USED IN IMAGING TECHNOLOGY, 1998-2003
Table 46 PATENTS BY SCHERING AG FOR REAGENTS USED IN IMAGING TECHNOLOGY, 1998-2003
Table 47 PATENTS BY POINT BIOMEDICAL FOR REAGENTS USED IN IMAGING TECHNOLOGY, 1998-2003
Table 48 PATENTS BY SONUS PHARMACEUTICALS FOR REAGENTS USED IN IMAGING TECHNOLOGY, 1998-2003
- PATENTS BY COUNTRY
Table 49 U.S. PATENTS BY COUNTRY, 1998-2003
Figure 14 U.S. PATENTS BY COUNTRY, 1998-2003
Table 50 TRENDS OF PATENTS ISSUED BY COUNTRY, 1998-2003
Figure 15 TOTAL U.S. NUMBER OF PATENTS ISSUED BY COUNTRY, 1998-2003
Figure 16 PERCENT OF PATENTS ISSUED BY COUNTRY, 1998-2003 (%)
PATENTS BY ASIGNEE
Table 51 SHARE OF U.S. PATENTS BY ASIGNEE, 1998-2003
Figure 17 MARKET SHARE OF U.S. PATENTS BY ASSIGNEE, 1998-2003 (NUMBER OF PATENTS)
Figure 18 MARKET SHARE OF U.S PATENTS BY ASSIGNEE, 1998-2003 (%)

MARKET BY APPLICATIONS

Table 52 U.S. SALES OF MEDICAL IMAGING REAGENTS BY APPLICATION, THROUGH 2008 ($ MILLIONS)
Figure 19 U.S. SALES OF MEDICAL IMAGING REAGENTS BY APPLICATION, 2001-2008 ($ MILLIONS)
Figure 20 MARKET SHARE OF MEDICAL IMAGING REAGENTS BY APPLICATION, 2003
Figure 20 (CONTINUED)
- CARDIOVASCULAR
Table 53 U.S. SALES OF TYPES OF MEDICAL IMAGING REAGENTS IN CARDIOVASCULAR APPLICATIONS, THROUGH 2008 ($ MILLIONS)
Figure 21 U.S. SALES OF TYPES OF MEDICAL IMAGING REAGENTS IN CARDIOVASCULAR APPLICATIONS, 2001-2008 ($ MILLIONS)
Figure 22 MARKET SHARE OF CARDIOVASCULAR IMAGING REAGENTS, 2003 (%)
Figure 22 (CONTINUED)
- CENTRAL NERVOUS SYSTEM (CNS)
Table 54 U.S. SALES OF TYPES OF MEDICAL IMAGING REAGENTS IN CENTRAL NERVOUS SYSTEM, THROUGH 2008 ($ MILLIONS)
Figure 23 U.S. SALES OF TYPES OF MEDICAL IMAGING REAGENTS IN CENTRAL NERVOUS SYSTEM IMAGING, 2001-2008 ($ MILLIONS)
Figure 24 MARKET SHARE OF CENTRAL NERVOUS SYSTEM IMAGING REAGENTS, 2003 (%)
Figure 24 (CONTINUED)
- GASTRO INTESTINAL (GIT) AND LIVER
Table 55 U.S. SALES OF TYPES OF MEDICAL IMAGING REAGENTS IN GASTROINTESTINAL AND LIVER IMAGING, THROUGH 2008 ($ MILLIONS)
Figure 25 U.S. SALES OF TYPES OF MEDICAL IMAGING REAGENTS IN GASTRO INTESTINAL AND LIVER IMAGING, 2001-2003 AND 2008 ($ MILLIONS)
Figure 26 MARKET SHARE OF GASTROINTESTAINAL AND LIVER IMAGING REAGENTS, 2003 (%)
Figure 26 (CONTINUED)
- ONCOLOGY
Table 56 U.S. SALES OF TYPES OF MEDICAL IMAGING REAGENTS IN ONCOLOGY IMAGING, THROUGH 2008 ($ MILLIONS)
Figure 27 U.S. SALES OF TYPES OF MEDICAL IMAGING REAGENTS IN ONCOLOGY IMAGING, 2001-2008 ($ MILLIONS)
Figure 28 MARKET SHARE OF ONCOLOGY IMAGING REAGENTS, 2003 ($ MILLIONS)
- OTHERS
Table 57 U.S. SALES OF TYPES OF MEDICAL IMAGING REAGENTS IN "OTHER" IMAGING, THROUGH 2008 ($ MILLIONS)
Figure 29 U.S. SALES OF TYPES OF MEDICAL IMAGING REAGENTS IN "OTHER" IMAGING, 2001-2008 ($ MILLIONS)
Figure 30 MARKET SHARE OF "OTHER" IMAGING REAGENTS, 2003 (%)
Figure 30 (CONTINUED)

INTERNATIONAL ASPECTS

UNITED STATES
EUROPE
JAPAN
REST OF THE WORLD
WORLDWIDE SALES OF X-RAY IMAGING REAGENTS

Table 58 WORLDWIDE SALES OF X-RAY IMAGING REAGENTS BY REGION, THROUGH 2008 ($ MILLIONS)
Figure 31 WORLDWIDE SALES OF X-RAY IMAGING REAGENTS BY REGION, 2001-2008 ($ MILLIONS)
- WORLDWIDE SALES OF ULTRASOUND IMAGING REAGENTS
Table 59 WORLDWIDE SALES OF ULTRASOUND IMAGING REAGENTS BY REGION, THROUGH 2008 ($ MILLIONS)
Figure 32 WORLDWIDE SALES OF ULTRASOUND IMAGING REAGENTS BY REGION, 2001-2008 ($ MILLIONS)
- WORLDWIDE SALES OF MRI IMAGING REAGENTS
Table 60 WORLDWIDE SALES OF MRI IMAGING REAGENTS BY REGION, THROUGH 2008 ($ MILLIONS)
Figure 33 WORLDWIDE SALES OF MRI IMAGING REAGENTS BY REGION, 2001-2008 ($ MILLIONS)
- WORLDWIDE SALES OF RADIOPHARMACEUTICALS/ NUCLEAR IMAGING REAGENTS
Table 61 WORLDWIDE SALES OF RADIOPHARMACEUTICALS/ NUCLEAR IMAGING REAGENTS BY REGION, THROUGH 2008 ($ MILLIONS)
Figure 34 WORLDWIDE SALES OF RADIOPHARMACEUTICALS/ NUCLEAR IMAGING REAGENTS BY REGION, 2001-2008 ($ MILLIONS)
- WORLDWIDE SALES AND MARKET SHARE OF IMAGING REAGENTS, BY REGION
Table 62 WORLDWIDE SALES OF IMAGING REAGENTS, BY REGION, THROUGH 2008 ($ MILLIONS)
Figure 35 WORLDWIDE SALES OF IMAGING REAGENTS, BY REGION, 2001-2008 ($ MILLIONS)
Figure 36 WORLDWIDE MARKET SHARE OF IMAGING REAGENTS, 2003 (%)

COMPANY PROFILES

ACUSPHERE INC.
ADVANCED MAGNETICS INC.
ALLIANCE PAHARMACEUTICALS CORP.
AMERSHAM HEALTH
BRACCO DIAGNOSTICS INC.
CYTOGEN CORPORATION
EPIX MEDICAL INC.
E-Z-EM, INC.
HOVIONE
IMARX THERAPEUTICS
IMMUNOMEDICS, INC.
KING PHAMACEUTICALS INC.
LAFAYETTE PHARMACEUTICALS, INC.
MALLINCKRODT MEDICAL
- MALLINCKRODT MEDICAL (CONTINUED)
NEORX
PHARMACYCLICS
SCHERING AG
- BERLEX LABORATORIES
- MEDRAD, INC.
POINT BIOMEDICAL
SONUS PHARMACEUTICALS

LIST OF TABLES

Summary Table: U.S. SALES OF MEDICAL IMAGING REAGENTS BY TYPE, THROUGH 2008 ($ MILLIONS)
Table 1 HISTORY OF IMAGING
Table 2 USE OF CT/X-RAY, ULTRASOUND AND MRI
Table 3 CHARACTERISTICS OF IMAGING TECHNIQUES
Table 4 ADVANTAGES OF NON-IONIC VS. IONIC CONTRAST AGENTS
Table 5 TYPES OF IODINE CONTAINING IMAGING REAGENTS FOR X-RAY/CT
Table 6 TYPES OF IONIC AND NON-IONIC IODINE CONTAINING IMAGING REAGENTS FOR X-RAY/CT
Table 7 USEFUL CLASSICAL RADIOPHARMACEUTICALS BY APPLICATION
Table 8 NEW AND GENERIC DRUG APPROVALS OF THE IMAGING REAGENTS, 2000-2003
Table 9 MARKET SHARE OF COMPANIES IN MEDICAL IMAGING REAGENTS, 2002 (%)
Table 10 MARKET SHARE OF COMPANIES IN X-RAYS AND CT IMAGING REAGENTS, 2002 (%)
Table 11 MARKET SHARE OF COMPANIES IN ULTRASOUND IMAGING REAGENTS, 2002 (%)
Table 12 MARKET SHARE OF COMPANIES IN MRI REAGENTS, 2002 (%)
Table 13 MARKET SHARE OF COMPANIES IN RADIOPHARMACEUTICAL IMAGING REAGENTS, 2002 (%)
Table 14 U.S. SALES OF IONIC AND NON-IONIC AGENTS, THROUGH 2008 ($ MILLIONS)
Table 15 REAGENTS USED IN X-RAY/CT
Table 16 U.S. SALES OF X-RAY/CT AGENTS, THROUGH 2008 ($ MILLIONS)
Table 17 U.S. SALES OF IONIC AND NON-IONIC REAGENTS IN X-RAY/CT IMAGING, THROUGH 2008 ($ MILLIONS)
Table 18 REAGENTS USED IN ULTRASOUND
Table 19 U.S. SALES OF ULTRASOUND REAGENTS, THROUGH 2008 ($ MILLIONS)
Table 20 CONTRAST AGENTS USED IN MRI
Table 21 U.S. SALES OF MRI AGENTS, THROUGH 2008 ($ MILLIONS)
Table 22 CONTRAST AGENTS USED IN RADIOPHARMACEUTICALS
Table 23 U.S. SALES OF RADIOPHARMACEUTICAL IMAGING REAGENTS, THROUGH 1008 ($ MILLIONS)
Table 24 X-RAY CONTRAST AGENTS UNDER DEVELOPMENT
Table 25 ULTRASOUND CONTRAST AGENTS UNDER DEVELOPMENT
Table 26 MRI CONTRAST AGENTS UNDER DEVELOPMENT
Table 27 RADIOPARMACEUTICAL CONTRAST AGENTS UNDER DEVELOPMENT
Table 28 NUMBER OF PATENTS BY TECHNOLOGY, 1998-2003
Table 29 SIGNIFICANT PATENTS OF X-RAY /CT REAGENTS, 1998-2003
Table 30 SIGNIFICANT PATENTS OF ULTRASOUND REAGENTS, 1998-2003
Table 31 SIGNIFICANT PATENTS OF MAGNETIC RESONANCE IMAGING REAGENTS, 1998-2003
Table 32 SIGNIFICANT PATENTS OF RADIOPHARMACEUTICAL REAGENTS, 1998-2003
Table 33 SIGNIFICANT PATENTS OF OTHER IMAGING REAGENTS1, 1998-2003
Table 34 PATENTS BY ACUSPHERE INC. FOR REAGENTS USED IN IMAGING TECHNOLOGY, 1998-2003
Table 35 PATENTS BY AMERSHAM HEALTH/ NYCOMED FOR REAGENTS USED IN IMAGING TECHNOLOGY, 1998-2003
Table 36 PATENTS BY ALLIANCE PHARMACEUTICALS CORP. FOR REAGENTS USED IN IMAGING TECHNOLOGY, 1998-2003
Table 37 PATENTS BY BRACCO FOR REAGENTS USED IN IMAGING TECHNOLOGY, 1998-2003
Table 38 PATENTS BY EPIX MEDICAL INC. FOR REAGENTS USED IN IMAGING TECHNOLOGY, 1998-2003
Table 39 PATENTS BY EZ-EM INC. FOR REAGENTS USED IN IMAGING TECHNOLOGY, 1998-2003
Table 40 PATENTS BY IMARX THERAPEUTICS FOR REAGENTS USED IN IMAGING TECHNOLOGY, 1998-2003
Table 41 PATENTS BY IMMUNOMEDICS FOR REAGENTS USED IN IMAGING TECHNOLOGY, 1998-2003
Table 42 PATENTS BY MALLINCKRODT MEDICAL FOR REAGENTS USED IN IMAGING TECHNOLOGY, 1998-2003
Table 43 PATENTS BY MOLECULAR BIOSYSTEMS FOR REAGENTS USED IN IMAGING TECHNOLOGY, 1998-2003
Table 44 PATENTS BY NEORX FOR REAGENTS USED IN IMAGING TECHNOLOGY, 1998-2003
Table 45 PATENTS BY PHARMACYCLICS FOR REAGENTS USED IN IMAGING TECHNOLOGY, 1998-2003
Table 46 PATENTS BY SCHERING AG FOR REAGENTS USED IN IMAGING TECHNOLOGY, 1998-2003
Table 47 PATENTS BY POINT BIOMEDICAL FOR REAGENTS USED IN IMAGING TECHNOLOGY, 1998-2003
Table 48 PATENTS BY SONUS PHARMACEUTICALS FOR REAGENTS USED IN IMAGING TECHNOLOGY, 1998-2003
Table 49 U.S. PATENTS BY COUNTRY, 1998-2003
Table 50 TRENDS OF PATENTS ISSUED BY COUNTRY, 1998-2003
Table 51 SHARE OF U.S. PATENTS BY ASIGNEE, 1998-2003
Table 52 U.S. SALES OF MEDICAL IMAGING REAGENTS BY APPLICATION, THROUGH 2008 ($ MILLIONS)
Table 53 U.S. SALES OF TYPES OF MEDICAL IMAGING REAGENTS IN CARDIOVASCULAR APPLICATIONS, THROUGH 2008 ($ MILLIONS)
Table 54 U.S. SALES OF TYPES OF MEDICAL IMAGING REAGENTS IN CENTRAL NERVOUS SYSTEM, THROUGH 2008 ($ MILLIONS)
Table 55 U.S. SALES OF TYPES OF MEDICAL IMAGING REAGENTS IN GASTROINTESTINAL AND LIVER IMAGING, THROUGH 2008 ($ MILLIONS)
Table 56 U.S. SALES OF TYPES OF MEDICAL IMAGING REAGENTS IN ONCOLOGY IMAGING, THROUGH 2008 ($ MILLIONS)
Table 57 U.S. SALES OF TYPES OF MEDICAL IMAGING REAGENTS IN "OTHER" IMAGING, THROUGH 2008 ($ MILLIONS)
Table 58 WORLDWIDE SALES OF X-RAY IMAGING REAGENTS BY REGION, THROUGH 2008 ($ MILLIONS)
Table 59 WORLDWIDE SALES OF ULTRASOUND IMAGING REAGENTS BY REGION, THROUGH 2008 ($ MILLIONS)
Table 60 WORLDWIDE SALES OF MRI IMAGING REAGENTS BY REGION, THROUGH 2008 ($ MILLIONS)
Table 61 WORLDWIDE SALES OF RADIOPHARMACEUTICALS/ NUCLEAR IMAGING REAGENTS BY REGION, THROUGH 2008 ($ MILLIONS)
Table 62 WORLDWIDE SALES OF IMAGING REAGENTS, BY REGION, THROUGH 2008 ($ MILLIONS)

LIST OF FIGURES

Summary Figure: U.S. SALES OF MEDICAL IMAGING REAGENTS BY TYPE, 2001-2008 ($ MILLIONS)
Figure 1 MARKET SHARE OF COMPANIES IN MEDICAL IMAGING REAGENTS, 2002 (%)
Figure 2 MARKET SHARE OF COMPANIES IN X-RAYS AND CT IMAGING REAGENTS, 2002 (%)
Figure 3 MARKET SHARE OF COMPANIES IN ULTRASOUND IMAGING REAGENTS, 2002 (%)
Figure 4 MARKET SHARE OF COMPANIES IN MRI REAGENTS, 2002 (%)
Figure 5 MARKET SHARE OF COMPANIES IN RADIOPHARMACEUTICAL REAGENTS, 2002 (%)
Figure 6 U.S. SALES OF IONIC AND NON-IONIC AGENTS, 2001-2008 ($ MILLIONS)
Figure 7 U.S. SALES OF X-RAY/CT AGENTS, 2001-2008 ($ MILLIONS)
Figure 8 U.S. SALES OF IONIC AND NON-IONIC REAGENTS IN X-RAY/CT IMAGING, 2001-2008 ($ MILLIONS)
Figure 9 U.S. SALES OF ULTRASOUND REAGENTS, 2001-2008 ($ MILLIONS)
Figure 10 U.S. SALES OF MRI AGENTS, 2001-2008 ($ MILLIONS)
Figure 11 U.S. SALES OF RADIOPHARMACEUTICAL IMAGING REAGENTS, 2001-2008 ($ MILLIONS)
Figure 12 NUMBER OF PATENTS, 1998-2003
Figure 13 NUMBER OF PATENTS BY YEAR, 1998-2003 (% OF TOTAL)
Figure 14 U.S. PATENTS BY COUNTRY, 1998-2003
Figure 15 TOTAL U.S. NUMBER OF PATENTS ISSUED BY COUNTRY, 1998-2003
Figure 16 PERCENT OF PATENTS ISSUED BY COUNTRY, 1998-2003 (%)
Figure 17 MARKET SHARE OF U.S. PATENTS BY ASSIGNEE, 1998-2003 (NUMBER OF PATENTS)
Figure 18 MARKET SHARE OF U.S PATENTS BY ASSIGNEE, 1998-2003 (%)
Figure 19 U.S. SALES OF MEDICAL IMAGING REAGENTS BY APPLICATION, 2001-2008 ($ MILLIONS)
Figure 20 MARKET SHARE OF MEDICAL IMAGING REAGENTS BY APPLICATION, 2003
Figure 21 U.S. SALES OF TYPES OF MEDICAL IMAGING REAGENTS IN CARDIOVASCULAR APPLICATIONS, 2001-2008 ($ MILLIONS)
Figure 22 MARKET SHARE OF CARDIOVASCULAR IMAGING REAGENTS, 2003 (%)
Figure 23 U.S. SALES OF TYPES OF MEDICAL IMAGING REAGENTS IN CENTRAL NERVOUS SYSTEM IMAGING, 2001-2008 ($ MILLIONS)
Figure 24 MARKET SHARE OF CENTRAL NERVOUS SYSTEM IMAGING REAGENTS, 2003 (%)
Figure 25 U.S. SALES OF TYPES OF MEDICAL IMAGING REAGENTS IN GASTRO INTESTINAL AND LIVER IMAGING, 2001-2003 AND 2008 ($ MILLIONS)
Figure 26 MARKET SHARE OF GASTROINTESTAINAL AND LIVER IMAGING REAGENTS, 2003 (%)
Figure 27 U.S. SALES OF TYPES OF MEDICAL IMAGING REAGENTS IN ONCOLOGY IMAGING, 2001-2008 ($ MILLIONS)
Figure 28 MARKET SHARE OF ONCOLOGY IMAGING REAGENTS, 2003 ($ MILLIONS)
Figure 29 U.S. SALES OF TYPES OF MEDICAL IMAGING REAGENTS IN "OTHER" IMAGING, 2001-2008 ($ MILLIONS)
Figure 30 MARKET SHARE OF "OTHER" IMAGING REAGENTS, 2003 (%)
Figure 31 WORLDWIDE SALES OF X-RAY IMAGING REAGENTS BY REGION, 2001-2008 ($ MILLIONS)
Figure 32 WORLDWIDE SALES OF ULTRASOUND IMAGING REAGENTS BY REGION, 2001-2008 ($ MILLIONS)
Figure 33 WORLDWIDE SALES OF MRI IMAGING REAGENTS BY REGION, 2001-2008 ($ MILLIONS)
Figure 34 WORLDWIDE SALES OF RADIOPHARMACEUTICALS/ NUCLEAR IMAGING REAGENTS BY REGION, 2001-2008 ($ MILLIONS)
Figure 35 WORLDWIDE SALES OF IMAGING REAGENTS, BY REGION, 2001-2008 ($ MILLIONS)
Figure 36 WORLDWIDE MARKET SHARE OF IMAGING REAGENTS, 2003 (%)